Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Transl Stroke Res. 2018 Oct 19;10(4):440–448. doi: 10.1007/s12975-018-0670-7

Fig. 1. Infarct size of the experimental study groups.

Fig. 1.

D192935 or vehicle was administered via intramuscular injection to male NHPs 3 days prior to the onset of surgical occlusion as described in [16]. T2-weighted MR imaging was performed on day 2 following reperfusion and infarct size determined as percent of total brain. Data presented are a subset of animals, chosen based on infarct size, from previously published study [16]. Study groups are shown as CNTL: Vehicle treated; Drug not protected (DNP): D192935 treated with large infarcts (Top Box); Drug protected (DP): D192935 treated with small infarcts (Bottom Box).